AI-generated summary
This Cochrane systematic review pooled five placebo-controlled randomized trials of low level laser therapy in 204 patients with rheumatoid arthritis. The authors report reductions in pain and morning stiffness relative to control, but outcomes were in conflict and they conclude firm documentation of LLLT's effect in RA is not possible.
- Participants
- 204
- Studies included
- 5
- Who or what was studied
- Patients with a clinical diagnosis of rheumatoid arthritis enrolled in five placebo-controlled randomized trials
- Limits stated in the abstract
- The authors state the pooled outcomes were in conflict, trials lacked standardized outcomes, and the analysis lacked data on wavelength, duration, dosage and site of application.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Wavelength, Control group, Heterogeneity, Meta-analysis, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.